What is Cyrisma?
Cyrisma operates as a comprehensive cybersecurity ecosystem designed to simplify the delivery of security services. The platform integrates vulnerability management, data discovery, and attack surface management into a cohesive interface, allowing MSPs and MSSPs to reduce tooling overhead while enhancing their service offerings. By focusing on the intersection of risk management and compliance, Cyrisma enables its partners to transform security from a cost center into a value-added revenue stream. With a user base exceeding 3,000 organizations, the company has established itself as a critical partner for businesses seeking to optimize their security posture through automation and centralized control.
How much funding has Cyrisma raised?
Cyrisma has raised a total of $7M across 1 funding round:
Other Financing Round
$7M
Other Financing Round (2024): $7M with participation from Blueprint Equity and SaaS Venture Partners
Key Investors in Cyrisma
Blueprint Equity
Blueprint Equity is a tech-focused growth equity firm that invests in and builds market-leading enterprise businesses, specializing in business-critical applications.
SaaS Venture Partners
SaaS Venture Partners is a custom software development firm that specializes in delivering high-quality solutions for startups and SMEs with a focus on scalability.
What's next for Cyrisma?
With this major enterprise-level funding, Cyrisma is well-positioned to accelerate its product roadmap and expand its market footprint. The strategic capital will likely be deployed toward enhancing the platform's AI-driven threat detection capabilities and deepening its integration with existing MSP workflows. As the company scales, the focus will remain on maintaining its competitive edge in the B2B software sector, ensuring that its partners can continue to deliver high-value security outcomes in an increasingly volatile digital environment. Future growth initiatives will likely prioritize international market penetration and the development of advanced compliance automation features to meet the rigorous demands of global regulatory frameworks.
See full Cyrisma company page
